This is today’s edition of The Download, our weekday newsletter that provides a daily dose of what’s going on in the world of technology. There’s a lot of hype around perimenopause. Don’t buy it. Perimenopause used to be considered taboo, but not anymore. Thanks at least in part to TV doctors and social media influencers,…
The fight over AI regulation isn’t about the technology — it’s about whether Washington or the states get to set the rules, and what happens to consumers caught in between.
This is today’s edition of The Download, our weekday newsletter that provides a daily dose of what’s going on in the world of technology. What we still don’t know about weight-loss drugs Weight-loss drugs have been back in the news this week. First, we heard that Eli Lilly, the company behind Mounjaro and Zepbound, became the first…